Les Meilleurs doctors pour le traitement de thrombocytopénie en Israël - TOP-13 des médecins

Coût de la consultation disponible sur demande.

• Les détails sur le médecin et sa spécialisation sont en cours de confirmation.
• Des informations supplémentaires sur les diplômes et l'expérience sont en cours de compilation.
• Veuillez revenir bientôt pour consulter un profil plus détaillé.

Le Dr El Hasid a réalisé plus de 300 transplantations de moelle osseuse et de sang de cordon ombilical à l'hôpital pour enfants Dana Dwek. Elle y dirige le service d'onco-hématologie et d'oncologie pédiatrique.

• Se spécialiser dans la transplantation de moelle osseuse et de sang de cordon ombilical spécifiquement pour les enfants
• Être formée au prestigieux City of Hope Hospital de Los Angeles
• Auteure de plus de 50 publications scientifiques et de 40 rapports de conférence
• Membre de l'American Association for Hematology et de l'Israeli Society for Pediatric Hematooncology

Le Dr Ram a pratiqué plusieurs centaines de greffes de cellules souches pour des troubles sanguins tels que la thrombocytopénie au centre médical Sourasky (Ichilov). Il possède une triple certification en médecine interne, en hématologie et en oncologie médicale.

• Spécialisation en hématologie et oncologie au New York Medical College
• Publier plus de 30 articles scientifiques sur les maladies du sang et l'oncologie
• Rédiger un chapitre dans un manuel médical
• Effectuer son internat à l'Université d'État de New York à Brooklyn

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Spécialisation en transplantation de moelle osseuse – Le Dr Shapira apporte une vaste expertise dans la gestion des cas de thrombocytopénie.

• Diplôme de la faculté de médecine de l'Université hébraïque en 1999
• Spécialisation en médecine interne au centre médical Hadassah
• Médecin senior en transplantation de moelle osseuse à Hadassah
• Parler anglais et hébreu

Le Dr Dror Levin dirige le département d'hémato-oncologie pédiatrique du centre médical Sourasky, se spécialisant dans les troubles sanguins chez l'enfant.

• Directeur de l'hémato-oncologie pédiatrique au centre médical Sourasky
• Expert dans le traitement des troubles de la coagulation sanguine chez l'enfant
• Spécialisé en hématologie et oncologie pédiatriques au centre médical pour enfants Schneider
• Membre de l'ISPHO – Association israélienne d'hémato-oncologie pédiatrique
• Études en oncologie des os et des tissus mous à l'Institut orthopédique Rizzoli en Italie

Le Dr Kirshner contribue activement à l'avancement de l'hématologie par le biais d'essais cliniques, notamment un essai de phase III pour le cancer de la prostate résistant à la castration.

• Effectuer une formation spécialisée en hématologie au Montefiore Medical Center
• Se spécialiser dans les approches de traitement axées sur la recherche
• Posséder une vaste expérience en médecine interne et en oncologie

Le Dr Fredi Aviv possède 31 ans d'expérience en onco-hématologie au centre médical Sourasky.

• Se spécialiser dans le diagnostic et le traitement des maladies du sang
• Longue expérience dans un centre médical de premier plan en Israël
• Se consacrer à la prestation de soins personnalisés pour les pathologies hématologiques complexes

Le Dr Gal Goldstein est un spécialiste en hémato-oncologie pédiatrique au centre médical Hadassah, classé par Forbes comme l'un des meilleurs médecins d'Israël.

• Chef du service d'oncologie et d'hémato-oncologie pédiatrique à l'hôpital Hadassah Ein Kerem
• Spécialisé en hémato-oncologie pédiatrique depuis plus de 20 ans
• Expert en rétinoblastome et en médecine de précision
• Membre de plusieurs associations internationales d'oncologie pédiatrique
• Réaliser des greffes de moelle osseuse haplo-identiques

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.